Olivier BAUD
Publications in international peer reviewed journals
· 98-1. O Baud, Y Ville, V Zupan, et al. Are neonatal brain lesions due to intrauterine infection related to mode of delivery? Brit J Obst Gynaecol 1998;105:121-4.
· 98-2. O Baud, T Lacaze-Masmonteil, A Montsaingeon, et al. Single blood donor exposure programme for preterm infants : a large open study and an analysis of the risk factors to multiple donor exposure. Eur J Pediat 1998;157:579-83.
· 98-3. O Baud, AM d'Allest, H Nedelcoux, et al. Positive rolandic sharp waves as an EEG marker for the early diagnosis of periventricular leukomalacia in very preterm neonates. J Pediatr 1998;132:813-7.
· 98-4. O Baud, Lebidois J, Van Peborgh P, Ville Y. Fetal and neonatal hypertension in twin-twin transfusion syndrome: a case report. Fetal Diagn Ther 1998;13:223-6.
· 99-1. O Baud, D Emilie, E Pelletier, et al. Amniotic fluid concentrations of TNF-a, Interleukin-1b and 6 in chorioamnionitis before 32 weeks gestation: histological associations and neonatal outcome. Brit J Obst Gynaecol 1999;106:72-77.
· 99-2. O Baud, V Zupan, T Lacaze-Masmonteil, M Dehan. Neurological adverse effects of very early postnatal dexamethasone therapy in preterm infants. Arch Dis Child 1999;80:F159.
· 99-3. O Baud, V Cormier-Daire, S Lyonnet, et al. 13q-deletion contiguous gene syndrome in retinoblastoma patients. Clin Genet 1999;55:478-82 .
· 99-4. O Baud, L Foix-L'Helias, M Kaminski, et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very preterm infants. N Engl J Med 1999;341:1190-6.
· 00-1. C Picard, O Baud, C Fieschi, JL Casanova. Diagnosis and management of inheritable disorders of IFNg-mediated immunity. Immunol Allergy Clin North Am 2000; 20:65-76.
· 00-2. O Baud, V Zupan, T Lacaze-Masmonteil, et al. The relationships between antenatal management, the cause of delivery and neonatal outcome in a large cohort of very preterm singleton infants. Br J Obstet Gynaecol 2000;107:877-84.
· 01-1. O Baud. Is perinatal dexamethasone treatment safe in preterm infants? Dev Med Child Neurol. 2001;86:23-5.
· 01-2. O Baud, O Goulet, D Canioni, et al. Successful allogenic bone marrow transplantation in immune dysregulation, polyendocrinopathy, enteropathy, X-linked enteropathy (IPEX). N Engl J Med 2001; 344:1758-62.
· 01-3. O Baud, V Picard, P Durand, et al. Intracerebral hemorrhage associated with a new antithronbin gene mutation in a neonate. J Pediatr, 2001;138, in press.
· 01-4. O.Baud, V. Laudenbach, P. Evrard, P. Gressens. Neurotoxic effects of fluorinated glucocorticoids preparations on the developing mouse brain: role of preservatives. Pediatr Res, in press.
Publications in french peer reviewed journals
· 92. JF Cloix, M Le Jossec, O Baud, R Pecquery, Y Giudicelli, JP Dausse. Echangeurs Na+/H+, récepteurs a2-adrénergiques, sensibilité au sodium et hypertension artérielle. C.R. Soc. Biol. 1992;186:377-86.
· 96-1. P Narcy, X Acquadro, O Baud. La dénudation d'une veine axillaire superficielle comme alternative à la pose de cathéters épicutanéocaves chez le nouveau-né. Arch Pediatr 1996;3:292-293.
· 96-2. O Baud, C Boithias, T Lacaze-Masmonteil, et al. Traitement des candidoses congénitales par l'Amphotéricine B: un cas de thrombopénie chez un très grand prématuré. Arch Pediatr 1996;3:831-2
· 96-3. O Baud, A Montsaingeon, T Lacaze-Masmonteil, et al. Transfusions itératives à partir d'un donneur unique chez le nouveau-né prématuré d'âge gestationnel < 31 SA. Flammarion médecine-sciences Journée parisienne de Pédiatrie 1996, 361-2.
· 97-1. O Baud, C Boithias, T Lacaze-Masmonteil, et al. Infection materno-fœtale à Candida albicans et grande prématurité. Arch Pediatr 1997;4:331-4.
· 97-2. C Boithias, O Baud, V Diaz, P André, M Dehan. Mortalité, morbidité et devenir des très grands prématurés nés à moins de 28 semaines d'aménorrhée: à propos d'une série de 173 enfants. Flammarion médecine-sciences Journée parisienne de Pédiatrie 1997.
· 98-1. O Baud, V Zupan et T Lacaze-Masmonteil. Leucomalacie périventriculaire du prématuré. Médecine Thérapeutique Pédiatrie 1998;1:409-18.
· 98-2. T Lacaze-Masmonteil, O Baud, P Blanchard, V Zupan, M Dehan. Avancées médicales et progrès techniques en réanimation néonatale. EMC Pédiatrie 1998.
· 98-3. S Dehri, O Baud, JL Chabernaud, A Montsaingeon, T Lacaze-Masmonteil, E Gross, M Dehan. Transfusions multiples à partir d'un don unique chez le prématuré d'âge gestationnal inférieur à 31 semaines. Progrès en Néonatologie, Vol 18, 1998, p 248-59.
· 99-1. O Baud, S Vaulont. Animaux génétiquement modifiés. Actualités en réanimation et urgences, SRLF 1999, p 201-19.
· 99-2. O Baud. Infection néonatale à Candida Albicans. Médecine Thérapeutique Pédiatrie 1999;2:111-6.
· 00-1. O Baud, P Gressens. Administration périnatale de dexamethasone: quels bénéfices chez le grand prématuré? Arch Fr Ped 2000 Jul;7:717-8.
· 01-1. O Baud. Corticothérapie périnatale: état de la question et perspectives thérapeutiques. Flammarion médecine-sciences Journée parisienne de Pédiatrie 2001.
Oral communications in international meetings
1997
American Pediatric Society / Society for Pediatric Research, 2-6/05/97, Washington DC, USA: Positive rolandic sharpe waves are early electro-encephalographic markers of periventricular leukomalacia.
1998
. 28th European of Perinatal Medicine, 10-13/06/98, Zagreb, Croatia:
- Mortality and morbidity of very preterm singletons according to circumstances of delivery.
- Neurological adverse effects of very early postnatal steroid therapy in preterm infants.
. XIV international congress "The fetus as a Patient", 12-15/05/98, Amsterdam, Netherlands:
Amniotic fluid concentrations of TNF-alpha, interleukin-1b and interleukin-6 in chorioamnionitis before 32 weeks' gestation: anatomical correlations and neonatal outcome.
. The Neonatal Society, summer meeting, 18-20/06/98, Rennes, France:
Impact of prenatal events on neonatal outcome of very preterm singletons.
. International symposium on periventricular leukomalacia, 30/11-01/12/98 Paris, France:
- Neurological adverse effects of very early postnatal steroid therapy in preterm infant
- Differential effect of antenatal Dexamethasone vs Betamethasone on the occurrence of white matter damage in very preterm infants.
1999
3rd European Pediatric Neurology Society, 7-10/11/99, Nice, France: Impact of antenatal betamethasone on the incidence of periventricular leukomalacia among very preterm infants.
2000
. Royal society of Medicine, 9-10/02/00, London, UK:
Neuroprotection of the infant brain (Mac Keith Meeting): is dexamethasone neurotoxic during brain development ?.
. 3rd World Congress on Pediatric Intensive Care, 25-29/06/00, Montréal, Canada:
A novel inherited point mutation responsible for antithrombin-III deficiency and neonatal brain thrombosis.
2001
. American Pediatric Society / Society for Pediatric Research, 2-6/05/01, Baltimore, USA: Toxic effect of fluorocorticoids on the developing neurons: role of stabilizing additives.
· 98-1. O Baud, Y Ville, V Zupan, et al. Are neonatal brain lesions due to intrauterine infection related to mode of delivery? Brit J Obst Gynaecol 1998;105:121-4.
· 98-2. O Baud, T Lacaze-Masmonteil, A Montsaingeon, et al. Single blood donor exposure programme for preterm infants : a large open study and an analysis of the risk factors to multiple donor exposure. Eur J Pediat 1998;157:579-83.
· 98-3. O Baud, AM d'Allest, H Nedelcoux, et al. Positive rolandic sharp waves as an EEG marker for the early diagnosis of periventricular leukomalacia in very preterm neonates. J Pediatr 1998;132:813-7.
· 98-4. O Baud, Lebidois J, Van Peborgh P, Ville Y. Fetal and neonatal hypertension in twin-twin transfusion syndrome: a case report. Fetal Diagn Ther 1998;13:223-6.
· 99-1. O Baud, D Emilie, E Pelletier, et al. Amniotic fluid concentrations of TNF-a, Interleukin-1b and 6 in chorioamnionitis before 32 weeks gestation: histological associations and neonatal outcome. Brit J Obst Gynaecol 1999;106:72-77.
· 99-2. O Baud, V Zupan, T Lacaze-Masmonteil, M Dehan. Neurological adverse effects of very early postnatal dexamethasone therapy in preterm infants. Arch Dis Child 1999;80:F159.
· 99-3. O Baud, V Cormier-Daire, S Lyonnet, et al. 13q-deletion contiguous gene syndrome in retinoblastoma patients. Clin Genet 1999;55:478-82 .
· 99-4. O Baud, L Foix-L'Helias, M Kaminski, et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very preterm infants. N Engl J Med 1999;341:1190-6.
· 00-1. C Picard, O Baud, C Fieschi, JL Casanova. Diagnosis and management of inheritable disorders of IFNg-mediated immunity. Immunol Allergy Clin North Am 2000; 20:65-76.
· 00-2. O Baud, V Zupan, T Lacaze-Masmonteil, et al. The relationships between antenatal management, the cause of delivery and neonatal outcome in a large cohort of very preterm singleton infants. Br J Obstet Gynaecol 2000;107:877-84.
· 01-1. O Baud. Is perinatal dexamethasone treatment safe in preterm infants? Dev Med Child Neurol. 2001;86:23-5.
· 01-2. O Baud, O Goulet, D Canioni, et al. Successful allogenic bone marrow transplantation in immune dysregulation, polyendocrinopathy, enteropathy, X-linked enteropathy (IPEX). N Engl J Med 2001; 344:1758-62.
· 01-3. O Baud, V Picard, P Durand, et al. Intracerebral hemorrhage associated with a new antithronbin gene mutation in a neonate. J Pediatr, 2001;138, in press.
· 01-4. O.Baud, V. Laudenbach, P. Evrard, P. Gressens. Neurotoxic effects of fluorinated glucocorticoids preparations on the developing mouse brain: role of preservatives. Pediatr Res, in press.
Publications in french peer reviewed journals
· 92. JF Cloix, M Le Jossec, O Baud, R Pecquery, Y Giudicelli, JP Dausse. Echangeurs Na+/H+, récepteurs a2-adrénergiques, sensibilité au sodium et hypertension artérielle. C.R. Soc. Biol. 1992;186:377-86.
· 96-1. P Narcy, X Acquadro, O Baud. La dénudation d'une veine axillaire superficielle comme alternative à la pose de cathéters épicutanéocaves chez le nouveau-né. Arch Pediatr 1996;3:292-293.
· 96-2. O Baud, C Boithias, T Lacaze-Masmonteil, et al. Traitement des candidoses congénitales par l'Amphotéricine B: un cas de thrombopénie chez un très grand prématuré. Arch Pediatr 1996;3:831-2
· 96-3. O Baud, A Montsaingeon, T Lacaze-Masmonteil, et al. Transfusions itératives à partir d'un donneur unique chez le nouveau-né prématuré d'âge gestationnel < 31 SA. Flammarion médecine-sciences Journée parisienne de Pédiatrie 1996, 361-2.
· 97-1. O Baud, C Boithias, T Lacaze-Masmonteil, et al. Infection materno-fœtale à Candida albicans et grande prématurité. Arch Pediatr 1997;4:331-4.
· 97-2. C Boithias, O Baud, V Diaz, P André, M Dehan. Mortalité, morbidité et devenir des très grands prématurés nés à moins de 28 semaines d'aménorrhée: à propos d'une série de 173 enfants. Flammarion médecine-sciences Journée parisienne de Pédiatrie 1997.
· 98-1. O Baud, V Zupan et T Lacaze-Masmonteil. Leucomalacie périventriculaire du prématuré. Médecine Thérapeutique Pédiatrie 1998;1:409-18.
· 98-2. T Lacaze-Masmonteil, O Baud, P Blanchard, V Zupan, M Dehan. Avancées médicales et progrès techniques en réanimation néonatale. EMC Pédiatrie 1998.
· 98-3. S Dehri, O Baud, JL Chabernaud, A Montsaingeon, T Lacaze-Masmonteil, E Gross, M Dehan. Transfusions multiples à partir d'un don unique chez le prématuré d'âge gestationnal inférieur à 31 semaines. Progrès en Néonatologie, Vol 18, 1998, p 248-59.
· 99-1. O Baud, S Vaulont. Animaux génétiquement modifiés. Actualités en réanimation et urgences, SRLF 1999, p 201-19.
· 99-2. O Baud. Infection néonatale à Candida Albicans. Médecine Thérapeutique Pédiatrie 1999;2:111-6.
· 00-1. O Baud, P Gressens. Administration périnatale de dexamethasone: quels bénéfices chez le grand prématuré? Arch Fr Ped 2000 Jul;7:717-8.
· 01-1. O Baud. Corticothérapie périnatale: état de la question et perspectives thérapeutiques. Flammarion médecine-sciences Journée parisienne de Pédiatrie 2001.
Oral communications in international meetings
1997
American Pediatric Society / Society for Pediatric Research, 2-6/05/97, Washington DC, USA: Positive rolandic sharpe waves are early electro-encephalographic markers of periventricular leukomalacia.
1998
. 28th European of Perinatal Medicine, 10-13/06/98, Zagreb, Croatia:
- Mortality and morbidity of very preterm singletons according to circumstances of delivery.
- Neurological adverse effects of very early postnatal steroid therapy in preterm infants.
. XIV international congress "The fetus as a Patient", 12-15/05/98, Amsterdam, Netherlands:
Amniotic fluid concentrations of TNF-alpha, interleukin-1b and interleukin-6 in chorioamnionitis before 32 weeks' gestation: anatomical correlations and neonatal outcome.
. The Neonatal Society, summer meeting, 18-20/06/98, Rennes, France:
Impact of prenatal events on neonatal outcome of very preterm singletons.
. International symposium on periventricular leukomalacia, 30/11-01/12/98 Paris, France:
- Neurological adverse effects of very early postnatal steroid therapy in preterm infant
- Differential effect of antenatal Dexamethasone vs Betamethasone on the occurrence of white matter damage in very preterm infants.
1999
3rd European Pediatric Neurology Society, 7-10/11/99, Nice, France: Impact of antenatal betamethasone on the incidence of periventricular leukomalacia among very preterm infants.
2000
. Royal society of Medicine, 9-10/02/00, London, UK:
Neuroprotection of the infant brain (Mac Keith Meeting): is dexamethasone neurotoxic during brain development ?.
. 3rd World Congress on Pediatric Intensive Care, 25-29/06/00, Montréal, Canada:
A novel inherited point mutation responsible for antithrombin-III deficiency and neonatal brain thrombosis.
2001
. American Pediatric Society / Society for Pediatric Research, 2-6/05/01, Baltimore, USA: Toxic effect of fluorocorticoids on the developing neurons: role of stabilizing additives.
©2001 Ph. Evrard
